Get started
Fullgoal CSI SH-HK-SZ Brand Name Drug Industry ETF UnitsFullgoal CSI SH-HK-SZ Brand Name Drug Industry ETF UnitsFullgoal CSI SH-HK-SZ Brand Name Drug Industry ETF Units

Fullgoal CSI SH-HK-SZ Brand Name Drug Industry ETF Units

No trades
See on Supercharts
Overview Chart
Analysis
Holdings Discussions Technicals Seasonals

Key stats


Assets under management (AUM)
‪675.54 M‬ CNY
Fund flows (1Y)
‪229.57 M‬ CNY
Dividend yield (indicated)
—
Discount/Premium to NAV
1.3%
Shares outstanding
‪747.69 M‬
Expense ratio
0.60%

About Fullgoal CSI SH-HK-SZ Brand Name Drug Industry ETF Units


Issuer
Fullgoal Fund Management Co., Ltd.
Brand
Fullgoal
Home page
fullgoal.com.cn
Inception date
Nov 24, 2021
Structure
Open-Ended Fund
Index tracked
China Securities Shanghai-Hong Kong-Shenzhen Innovative Medicine Industry Index
Replication method
Physical
Management style
Passive
Dividend treatment
Distributes
Primary advisor
Fullgoal Fund Management Co., Ltd.
ISIN
CNE1000054J8
Closely track underlying index,Tightly track the target and minimize the deviation.

Classification


Asset Class
Equity
Category
Sector
Focus
Industrials
Niche
Broad-based
Strategy
Vanilla
Geography
China
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance——————
NAV total return——————

What's in the fund


As of December 31, 2024
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks89.54%
Health Technology88.52%
Commercial Services0.93%
Electronic Technology0.02%
Non-Energy Minerals0.02%
Process Industries0.01%
Consumer Services0.01%
Producer Manufacturing0.00%
Consumer Durables0.00%
Bonds, Cash & Other10.46%
Miscellaneous9.50%
Cash0.96%
Stock breakdown by region
1%98%
Asia98.43%
Europe1.57%
North America0.00%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows



Frequently Asked Questions


159748 invests in stocks. The fund's major sectors are Health Technology, with 88.52% stocks, and Commercial Services, with 0.93% of the basket. The assets are mostly located in the Asia region.
159748 top holdings are WuXi AppTec Co., Ltd. Class A and Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A, occupying 10.03% and 9.97% of the portfolio correspondingly.
159748 assets under management is ‪675.54 M‬ CNY. It's risen 42.97% over the last month.
159748 fund flows account for ‪229.57 M‬ CNY (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, 159748 doesn't pay dividends to its holders.
159748 shares are issued by Fullgoal Fund Management Co., Ltd. under the brand Fullgoal. The ETF was launched on Nov 24, 2021, and its management style is Passive.
159748 expense ratio is 0.60% meaning you'd have to pay 0.60% of your investment to help manage the fund.
159748 follows the China Securities Shanghai-Hong Kong-Shenzhen Innovative Medicine Industry Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
159748 invests in stocks.
159748 price has risen by 9.01% over the last month, and its yearly performance shows a 85.08% increase. See more dynamics on 159748 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 7.99% over the last month, showed a 20.43% increase in three-month performance and has increased by 87.26% in a year.
159748 trades at a premium (1.30%) meaning the ETF is trading at a higher price than the calculated NAV.